A) Reducing the use of all medications identified in the study.
B) Implementing closer monitoring of liver-related laboratory tests for patients on high-risk medications.
C) Increasing the dosage of hepatotoxic medications gradually.
D) Completely banning the use of identified high-risk medications.
